Please login to the form below
cell and genetic therapies
This page shows the latest cell and genetic therapies news and features for those working in and with pharma, biotech and healthcare.
Astellas invests $50m to support advancement of Poseida’s cancer cell therapy
In oncology, Poseida’s research and development of cell and gene therapies for cancer and rare genetic diseases provides a broad pipeline of allogeneic CAR-T cell therapy product candidates for ... Mark Gergen, chief executive officer at Poseida, said:
Latest news
-
Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
VX-880 is a stem-cell-derived, fully differentiated pancreatic islet cell replacement therapy that is delivered as a single infusion. ... These results from the first patient treated with VX-880 are unprecedented,” said Vertex’s head of cell and
-
Vertex expands further into cell and genetic therapies with a deal worth up to $1.2bn
This new collaboration further expands our toolkit in cell and genetic therapies and, specifically, our work to discover and develop cell therapies for the treatment of multiple serious diseases,” said Vertex ... The deal with Arbor further enhances
-
Vertex to lead development of CRISPR Therapeutics-partnered gene therapy
Cell and genetic therapies are key to our strategy of developing transformative therapies for serious diseases, and this agreement is an important next step in cementing our leadership in these modalities ... as we bring forward our broad gene and
-
Vertex gains FDA fast track designation for diabetes stem cell therapy
The US Food and Drug Administration (FDA) has granted Vertex’s investigational stem cell therapy VX-880 a fast track designation for type 1 diabetes (T1D). ... the team at Vertex,” said Bastiano Sanna, executive vice president and chief of cell and
-
bluebird bio to separate oncology and rare diseases units
Over the last decade, bluebird bio has pioneered development of gene and cell therapies for severe genetic diseases and oncology – delivering transformative outcomes for patients,” said Leschly. ... bluebird bio will continue to focus on delivering
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest Intelligence
-
The importance of medical affairs
With increasing knowledge about genetic factors, biomarkers and targeted therapies, medical affairs will need to stay at the forefront of scientific advancements and guide the integration of personalised medicine into clinical ... practice. They will
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Innovation in pharma: the highs and lows of the current healthcare economy
While the likely premium price of upcoming genetic and cell-based therapies challenges traditional NHS funding mechanisms, the continuing influx of biosmilars is driving down the cost of biologics. ... These treatments could eliminate future costs
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
